grant

Improved Understanding of Bacterial Sortase Activity Towards Next-Generation Protein Engineering

Organization WESTERN WASHINGTON UNIVERSITYLocation BELLINGHAM, UNITED STATESPosted 1 May 2024Deadline 30 Apr 2027
NIHUS FederalResearch GrantFY20242019 novel corona virus2019 novel coronavirus2019-nCoV2019-nCoV vaccineAffectAffinityAfrica South of the SaharaAminesAntibiotic AgentsAntibiotic DrugsAntibiotic ResistanceAntibioticsAntimicrobial ResistanceAssayB anthracisB. anthracisBacillus anthracisBacteriaBasic ResearchBasic ScienceBindingBinding ProteinsBioassayBiochemicalBiological AssayBiologyBiotinC-terminalCOVID-19 vaccineCOVID-19 virusCOVID19 virusCatalysisCell WallCell surfaceCessation of lifeCharacteristicsChemicalsChimeraChimera organismClosure by LigationCoV-2CoV2Computational BiologyCysteineDeathDevelopmentDiagnostic testsDimerizationDiseaseDisorderDrug resistanceEngineeringEnzyme GeneEnzymesEventFRETFluorescence Resonance Energy TransferFoundationsFörster Resonance Energy TransferGenetic AlterationGenetic ChangeGenetic defectGram-Positive BacteriaHalf-CystineHandHealthHigh Throughput AssayHumanIn VitroKnowledgeL monocytogenesL-CysteineL. monocytogenesLengthLigand Binding ProteinLigand Binding Protein GeneLigationLipidsListeriaListeria monocytogenesMRSAMapsMeasuresMediatingMethicillin Resistant S. AureusMethodologyMethodsMiscellaneous AntibioticMissionModelingModern ManMolecularMolecular ConfigurationMolecular ConformationMolecular Dynamics SimulationMolecular InteractionMolecular StereochemistryMureinMutationNIGMSNational Institute of General Medical SciencesNerve DegenerationNeuron DegenerationPeptide SynthesisPeptidesPeptidoglycanPeptidyl TransferasesPeptidyl TranslocasesPeptidyltransferasePhasePlayPositionPositioning AttributeProductivityProtein BindingProtein BiochemistryProtein DimerizationProtein DynamicsProtein EngineeringProtein FamilyProtein/Amino Acid BiochemistryProteinsPublic HealthReactionReportingResearchResistance to antibioticsResistant S. PneumoniaeResistant Streptococcus pneumoniaeResistant to antibioticsRoleS aureusS pyogenesS. aureusS. pyogenesSARS corona virus 2SARS-CO-V2SARS-COVID-2SARS-CoV-2SARS-CoV-2 vaccineSARS-CoV2SARS-associated corona virus 2SARS-associated coronavirus 2SARS-coronavirus-2SARS-coronavirus-2 vaccineSARS-related corona virus 2SARS-related coronavirus 2SARSCoV2SeriesSevere Acute Respiratory Coronavirus 2Severe Acute Respiratory Distress Syndrome CoV 2Severe Acute Respiratory Distress Syndrome Corona Virus 2Severe Acute Respiratory Distress Syndrome Coronavirus 2Severe Acute Respiratory Syndrome CoV 2Severe Acute Respiratory Syndrome CoV 2 vaccineSevere Acute Respiratory Syndrome-associated coronavirus 2Severe Acute Respiratory Syndrome-related coronavirus 2Severe acute respiratory syndrome associated corona virus 2Severe acute respiratory syndrome coronavirus 2Severe acute respiratory syndrome coronavirus 2 vaccineSevere acute respiratory syndrome related corona virus 2SpecificityStaph aureusStaphylococcus aureusStrepavidinStreptavidinStreptococcusStreptococcus Group AStreptococcus pyogenesSub-Saharan AfricaSubsaharan AfricaSubstrate InteractionSystemTM DomainTechniquesTestingTransmembrane DomainTransmembrane RegionTranspeptidasesVariantVariationVitamin HWorkWuhan coronavirusabeta accumulationabeta aggregationamineamyloid beta accumulationamyloid beta aggregationamyloid β accumulationamyloid β aggregationanthracisanti-microbial resistantantibiotic designantibiotic drug resistanceantibiotic resistantarmaβ accumulationaβ aggregationbacteria pathogenbacterial pathogenbound proteinchemical reaction ratechimerascoenzyme Rcomputer biologyconformationconformationalconformational stateconformationallyconformationscoronavirus disease 2019 vaccinecoronavirus disease 2019 viruscoronavirus disease-19 vaccinecoronavirus disease-19 virusdevelopmentaldrug resistantevaluate vaccinesflexibilityflexiblegenetic protein engineeringgenome mutationhCoV19handshigh throughput screeningimprovedinnovateinnovationinnovativemethicillin resistance Staphylococcus aureusmethicillin resistant Staphylococcus aureusmethicillin resistant strains of Staphylococcus aureusmolecular dynamicsnCoV vaccinenCoV-19 vaccinenCoV19 vaccinenCoV2nanobodiesnanobodynanodiskneural degenerationneurodegenerationneurodegenerativeneurological degenerationneuronal degenerationnext generationpathogenpathogenic bacteriapreferenceprotein designprotein purificationreaction rateresistance to Drugresistance to anti-microbialresistant strains of S. Pneumoniaeresistant to Drugresistant to antimicrobialsdAbsingle domain antibodiessocial rolesortasesrtA gene productstructural biologytherapeutic targettooltransacylationvaccine against 2019-nCovvaccine against COVID-19vaccine against SARS-CoV-2vaccine against SARS-coronavirus-2vaccine against Severe Acute Respiratory Syndrome CoV 2vaccine against Severe acute respiratory syndrome coronavirus 2vaccine candidates against SARS-CoV-2vaccine evaluationvaccine for novel coronavirusvaccine screeningvaccine testingvaccines preventing COVIDvaccines to prevent COVID
Sign up free to applyApply link · pipeline · email alerts
— or —

Get email alerts for similar roles

Weekly digest · no password needed · unsubscribe any time

Full Description

Project Summary. Sortase enzymes are cysteine transpeptidases located on the cell surface of Gram-positive
bacteria, which attach a variety of proteins to the peptidoglycan cell wall. The first sortase discovered, the Class

A sortase from Staphylococcus aureus (saSrtA), is widely used in sortase-mediated ligation (SML) or sortagging

protein engineering applications. This is a versatile protein with numerous human health and disease

implications; recent examples include the use of an engineered saSrtA to identify and disrupt amyloid-b

aggregates in a neurodegeneration model and to construct multi-arm SARS-CoV-2 neutralizing nanobodies.

SrtA is also a potential antibiotic target, as it is an essential protein in these pathogenic bacteria. However, recent

work from ourselves and others reveals that the stringent target selectivity of saSrtA is not shared amongst other

Class A sortases, e.g., those from the Streptococcus or Listeria genera. Furthermore, other classes of sortases

are extremely understudied with respect to SrtA proteins, and could provide useful tools for SML applications.

Class B sortases (SrtBs), for example, recognize a different motif sequence, which may be exploited to expand

the capabilities of SML. Finally, early evidence suggests that the transmembrane region of saSrtA may play an

important role in the catalytic efficiency of this enzyme, but this has not been thoroughly investigated.

The overall objectives in this application are to (i) dissect selectivity and activity determinants in sortase

enzymes from multiple classes, including the transmembrane regions of sortases and/or their substrates, and

(ii) use bacterial display to create a high throughput assay to measure sortase selectivity, which would be

applicable broadly to all classes of sortases. The central hypothesis is that we can use protein biochemistry,

chemical biology, and computational biology to better understand these enzymes. The rationale of this project is

that a deep understanding of the general characteristics of sortase biology can be leveraged to develop new

SML strategies for protein engineering, and assist in targeted antibiotic design to improve human health. The

central hypothesis will be tested by pursuing three specific aims: 1) dissect selectivity and activity determinants

in SrtA enzymes by characterizing differences in protein dynamics and elucidating extended motif preferences,

as well as develop a high throughout bacterial display assay for sortase selectivity, 2) advance a molecular

understanding of SrtB activities in order to improve reaction rates, and 3) characterize the role of the

transmembrane regions of sortase and its substrates in catalysis. All aims will utilize protein biochemistry,

structural biology, chemical biology, and computational biology. The research proposed in this application is

innovative in that we will be developing new assays and applying techniques not previously used with sortase

enzymes, continuing our work as a productive collaborative team to investigate aspects of sortase enzymes not

currently well understood. The proposed research is significant because our work will inform next-generation

SML methods and can be applied to the development of new antibiotics for Gram-positive bacterial pathogens.

Grant Number: 1R15GM154315-01
NIH Institute/Center: NIH

Principal Investigator: Jeanine Amacher

Sign up free to get the apply link, save to pipeline, and set email alerts.

Sign up free →

Agency Plan

7-day free trial

Unlock procurement & grants

Upgrade to access active tenders from World Bank, UNDP, ADB and more — with email alerts and pipeline tracking.

$29.99 / month

  • 🔔Email alerts for new matching tenders
  • 🗂️Track tenders in your pipeline
  • 💰Filter by contract value
  • 📥Export results to CSV
  • 📌Save searches with one click
Start 7-day free trial →